bms204352 has been researched along with mefenamic acid in 2 studies
| Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (mefenamic acid) | Trials (mefenamic acid) | Recent Studies (post-2010) (mefenamic acid) |
|---|---|---|---|---|---|
| 49 | 1 | 12 | 1,180 | 158 | 267 |
| Protein | Taxonomy | bms204352 (IC50) | mefenamic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 1.6 | |
| Myeloperoxidase | Homo sapiens (human) | 1.595 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.116 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.751 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.56 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 6.97 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 3.91 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 review(s) available for bms204352 and mefenamic acid
| Article | Year |
|---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
1 other study(ies) available for bms204352 and mefenamic acid
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |